Clinical Trial Update: Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer

View source ↗

Summary

A clinical trial aims to identify dosimetric parameters that correlate with acute hematologic toxicity in rectal cancer patients. The study status is listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Rectal Neoplasm | Status: UNKNOWN